logo
logo
AI Products 

In Silico Clinical Trials Market - Global Industry Size, Share, Trends, and Forecast 2027

avatar
Shipra Joshi
In Silico Clinical Trials Market - Global Industry Size, Share, Trends, and Forecast 2027

Global In Silico Clinical Trials market stood at USD2743.64 million in 2021 and is expected to grow at a CAGR of 12.28% during the forecast period. The growing factors of the market are: growing prevalence of various communicable and non-communicable diseases such as cancer, diabetes, cardiovascular diseases, neurological disorders, SARS-CoV-2 among others requiring different drugs and medical devices for the treatment.


Rapidly Increasing Concerns Over Animal Welfare


In January 2020, the US Department of Agriculture had reported that approximately 300,000 animals were involved in pain causing experimental activities in just one year. In silico clinical trials offer an effective way of replacing animal anatomies for conducting various experiments and research & development activities.


Benefits Associated with In Silico Clinical Trials

Numerous benefits associated with In Silico Clinical Trials such as their cost effectiveness in terms of pharmaceutical and therapeutic research, their ability to assess without any significant delays and additional resources thereby increasing their scalability, ensuring animal safety, among others are expected to support the market growth through 2027.


Market Segmentation

The global In Silico Clinical Trials market segmentation is based on industry, therapeutic area, region and company. Regionally, North America dominated the market in 2021 among Europe, Asia Pacific, South America and Middle East & Africa.


In North America, the United States dominated the market with an overall share of 77.01% in 2021 on account of increasing use case scenario in the United States such as the testing of mini-invasive total hip replacement known as Proximal Epiphyseal Replacement device designed by Stryker Corporation.


Company Profile:

Market Size value in 2021 - USD2743.64 Million

Revenue Forecast in 2027 - USD5451.19 Million

United States Market Size Value in 2021 - USD853.60 Million

Growth Rate - 12.28%

Base Year - 2021

Historical Years - 2017 – 2020

Estimated Year - 2022

Forecast Period - 2023 – 2027

Quantitative Units - Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage - Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered - Industry and Therapeutic Area

Regional Scope - North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope - United States; Canada; Mexico; Germany; Italy; United Kingdom; France; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key Companies Profiled - Dassault Systèmes SE, Certara Inc., Insilico Medicine, GNS Healthcare Inc., The AnyLogic Company, Novadiscovery SAS, InSilicoTrials Technologies SpA, Immunetrics Inc, CATO SMS, Evotec SE

Customization Scope - 10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options - Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format - PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)


Table of Content:


1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global In Silico Clinical Trials Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Factors Contributing to Switch to In Silico Clinical Trials

5.3.  Demand for In Silico Clinical Trials, By Therapeutic Area

5.4.  Preference for In Silico Clinical Trials, By Industry

6.    Global In Silico Clinical Trials Market Outlook, 2017-2027F

6.1.  Market Size & Forecast

6.2.  Market Share & Forecast

6.3.  Product Market Map

7.    North America In Silico Clinical Trials Market Outlook, 2017-2027F

7.1.  Market Size & Forecast          

7.2.  Market Share & Forecast

7.3.  North America: Country Analysis

7.3.2.     Canada In Silico Clinical Trials Market Outlook

7.3.3.     Mexico In Silico Clinical Trials Market Outlook

8.    Europe In Silico Clinical Trials Market Outlook, 2017-2027F

9.    Asia-Pacific In Silico Clinical Trials Market Outlook, 2017-2027F

10.  South America In Silico Clinical Trials Market Outlook, 2017-2027F

11.  Middle East and Africa In Silico Clinical Trials Market Outlook, 2017-2027F

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends and Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

15.  Strategic Recommendations

16.  About Us & Disclaimer

collect
0
avatar
Shipra Joshi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more